deoxyfuconojirimycin has been researched along with melphalan in 1 studies
| Studies (deoxyfuconojirimycin) | Trials (deoxyfuconojirimycin) | Recent Studies (post-2010) (deoxyfuconojirimycin) | Studies (melphalan) | Trials (melphalan) | Recent Studies (post-2010) (melphalan) |
|---|---|---|---|---|---|
| 20 | 0 | 6 | 8,134 | 1,351 | 1,972 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carty, MP; Herold-Mende, C; Mirallai, SI; Murphy, PV; Negi, A; Warta, R; Ye, XS; Zhou, J | 1 |
1 other study(ies) available for deoxyfuconojirimycin and melphalan
| Article | Year |
|---|---|
N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines.
Topics: 1-Deoxynojirimycin; alpha-L-Fucosidase; Bacteria; Bacterial Proteins; Binding Sites; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; Immunoglobulin G; Inhibitory Concentration 50; Melphalan; Molecular Docking Simulation; Structure-Activity Relationship; Sugar Alcohols | 2019 |